MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle
- PMID: 17914108
- DOI: 10.1677/ERC-07-0129
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle
Abstract
We have recently reported that MicroRNAs (miR)-221 and miR-222 were up-regulated in human thyroid papillary carcinomas in comparison with the normal thyroid tissue. Bioinformatic analysis proposed the p27(Kip1) protein, a key regulator of cell cycle, as a candidate target for the miR-221/222 cluster. Here, we report that the enforced expression of miR-221 and miR-222 was able to reduce p27(Kip1) protein levels in thyroid carcinoma and HeLa cells in the absence of significant changes in specific p27(Kip1) mRNA levels. This effect is direct as miR-221 and miR-222 negatively regulate the expression of the 3'-untranslated region-based reporter construct from the p27(Kip1) gene, and is dependent on two target sites in this region. Consistent with these results, an enforced expression of the miR-221 and miR-222 induced the thyroid papillary carcinoma cell line (TPC-1) to progress to the S phase of the cell cycle. It is likely that the negative regulation of p27(Kip1) by miR-221 and miR-222 might also have a role in vivo since we report an inverse correlation between miR-221 and miR-222 up-regulation and down-regulation of the p27(Kip1) protein levels in human thyroid papillary carcinomas. Therefore, the data reported here demonstrate that miR-221 and miR-222 are endogenous regulators of p27(Kip1) protein expression, and thereby, the cell cycle.
Similar articles
-
[Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Dec;26(6):634-8. doi: 10.3760/cma.j.issn.1003-9406.2009.06.006. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19953484 Chinese.
-
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.Oncogene. 2008 Sep 25;27(43):5651-61. doi: 10.1038/onc.2008.178. Epub 2008 Jun 2. Oncogene. 2008. PMID: 18521080
-
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.Carcinogenesis. 2005 Jun;26(6):1021-34. doi: 10.1093/carcin/bgi050. Epub 2005 Feb 17. Carcinogenesis. 2005. PMID: 15718252
-
Regulation of p27(kip1) mRNA expression by microRNAs.Prog Mol Subcell Biol. 2010;50:59-70. doi: 10.1007/978-3-642-03103-8_4. Prog Mol Subcell Biol. 2010. PMID: 19841881 Review.
-
miR-10 in development and cancer.Cell Death Differ. 2010 Feb;17(2):209-14. doi: 10.1038/cdd.2009.58. Epub 2009 May 22. Cell Death Differ. 2010. PMID: 19461655 Review.
Cited by
-
Expression of miR-221 in colon cancer correlates with prognosis.Int J Clin Exp Med. 2015 Feb 15;8(2):2794-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932237 Free PMC article.
-
MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.Thyroid. 2012 Jan;22(1):9-16. doi: 10.1089/thy.2011.0081. Epub 2011 Dec 2. Thyroid. 2012. PMID: 22136206 Free PMC article.
-
MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression.PLoS One. 2012;7(1):e30030. doi: 10.1371/journal.pone.0030030. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272270 Free PMC article.
-
Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.Exp Hematol Oncol. 2013 Apr 8;2(1):10. doi: 10.1186/2162-3619-2-10. Exp Hematol Oncol. 2013. PMID: 23566596 Free PMC article.
-
Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer.Genet Mol Biol. 2020 Mar 2;43(1):e20180269. doi: 10.1590/1678-4685-GMB-2018-0269. eCollection 2020. Genet Mol Biol. 2020. PMID: 31487369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous